Medical and Pharmaceutical
The biotech company will be revealing 3-year safety data on its primary drug for Duchenne muscular dystrophy next week
Hi, what are you looking for?
Hi, what are you looking for?
The biotech company will be revealing 3-year safety data on its primary drug for Duchenne muscular dystrophy next week
